ResMed Inc.
RSMDF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,336 | $1,348 | $1,292 | $1,282 |
| % Growth | -0.9% | 4.4% | 0.8% | – |
| Cost of Goods Sold | $515 | $528 | $525 | $531 |
| Gross Profit | $821 | $820 | $766 | $751 |
| % Margin | 61.5% | 60.8% | 59.3% | 58.6% |
| R&D Expenses | $87 | $86 | $84 | $81 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $259 | $265 | $245 | $242 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $28 | $14 | $11 | $11 |
| Operating Expenses | $374 | $366 | $340 | $334 |
| Operating Income | $447 | $455 | $426 | $417 |
| % Margin | 33.4% | 33.7% | 33% | 32.5% |
| Other Income/Exp. Net | $0 | $4 | -$9 | $1 |
| Pre-Tax Income | $447 | $458 | $418 | $418 |
| Tax Expense | $98 | $78 | $53 | $74 |
| Net Income | $349 | $380 | $365 | $345 |
| % Margin | 26.1% | 28.2% | 28.3% | 26.9% |
| EPS | 2.38 | 2.59 | 2.49 | 2.35 |
| % Growth | -8.1% | 4% | 6% | – |
| EPS Diluted | 2.37 | 2.58 | 2.48 | 2.34 |
| Weighted Avg Shares Out | 146 | 146 | 147 | 147 |
| Weighted Avg Shares Out Dil | 147 | 147 | 147 | 148 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $6 | $1 | $0 |
| Interest Expense | $9 | $0 | $0 | $5 |
| Depreciation & Amortization | $48 | $74 | $52 | $56 |
| EBITDA | $503 | $532 | $470 | $479 |
| % Margin | 37.7% | 39.5% | 36.4% | 37.4% |